Related references
Note: Only part of the references are listed.Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication
Ulrika Kjellstrom et al.
ACTA OPHTHALMOLOGICA (2014)
Vigabatrin-associated retinal damage - potential biochemical mechanisms
M. K. Heim et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Electroretinographic (ERG) responses in pediatric patients using vigabatrin
Anne Moskowitz et al.
DOCUMENTA OPHTHALMOLOGICA (2012)
Evidence-based guideline update: Medical treatment of infantile spasms Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
C. Y. Go et al.
NEUROLOGY (2012)
Registry initiated to characterize vision loss associated with vigabatrin therapy
John M. Pellock et al.
EPILEPSY & BEHAVIOR (2011)
Electroretinogram Changes in a Pediatric Population With Epilepsy: Is Vigabatrin Acting Alone?
Blathnaid McCoy et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review
Melissa J. Maguire et al.
EPILEPSIA (2010)
Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?
Iiris Sorri et al.
EPILEPSY RESEARCH (2010)
Vigabatrin for the Treatment of Infantile Spasms: Final Report of a Randomized Trial
Roy D. Elterman et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats
Firas Jammoul et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin Final Results from an Open-Label, Observational, Multicentre Study
John M. Wild et al.
CNS DRUGS (2009)
Visual fields at school-age in children treated with vigabatrin in infancy
Eija Gaily et al.
EPILEPSIA (2009)
Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy
Miriam Conway et al.
EPILEPSIA (2008)
Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina
Qing-Ping Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Idiosyncratic adverse reactions to antiepileptic drugs
Gaetano Zaccara et al.
EPILEPSIA (2007)
A pharmacogenetic exploration of vigabatrin-induced visual field constriction
Peter Kinirons et al.
EPILEPSY RESEARCH (2006)
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial
AL Lux et al.
LANCET NEUROLOGY (2005)
Visual function in epilepsy patients treated with initial valproate monotherapy
I Sorri et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2005)
Reduced visual function associated with infantile spasms in children on vigabatrin therapy
DS Hammoudi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
A controlled study comparing visual function in patients treated with vigabatrin and tiagabine
GL Krauss et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Visual field constriction in 91 Finnish children treated with vigabatrin
S Vanhatalo et al.
EPILEPSIA (2002)
Randomized trial of vigabatrin in patients with infantile spasms
RD Elterman et al.
NEUROLOGY (2001)
Visual field constriction - Accumulation of vigabatrin but not tiagabine in the retina
GJ Sills et al.
NEUROLOGY (2001)
The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss
P Hardus et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2001)
Share Paper
